Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.68 | N/A |
PEG Ratio (TTM) | 0.01 | N/A |
P/S Ratio (TTM) | 6.17 | N/A |
P/B Ratio (TTM) | 0.70 | N/A |
P/FCF Ratio (TTM) | -708.90 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.03% | N/A |
ROE (TTM) | -37.57% | N/A |
Net Profit Margin (TTM) | -266.78% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -548.29% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -360.66% | N/A | N/A |
Cash Flow | -100.37% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.12 | N/A |
Quick Ratio (TTM) | 0.12 | N/A |
D/E Ratio (TTM) | 1.19 | N/A |
Interest Coverage (TTM) | -1.74 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |